TOTAL VOLUME:

$159.5b

24H VOL:

$140,398,419

24H TRANSACTIONS:

3,097,314,247

OPEN INTEREST:

$1,585,222,231

346,189

Markets across

36,265

events

MATCHED EVENTS:

3,446

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Tour
All
Measles cases in U.S. by October 31?
polymarket

Measles cases in U.S. by October 31?

Volume:
$39,609

4800+

 - Polymarket

4800+ - Polymarket

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Nov 1, 2026

Closed: Oct 30, 2:08 PM ET

polymarket

Polymarket

View
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
polymarket

4800+

View
100%
Yes 100¢No 0¢
—
N/A
$9,470
N/A
N/A
N/A
Settled
Yes
polymarket

4500+

100%
Yes 100¢No 0¢
—
N/A
$6,637
N/A
N/A
N/A
Settled
Yes
polymarket

4700+

100%
Yes 100¢No 0¢
—
N/A
$6,349
N/A
N/A
N/A
Settled
Yes
polymarket

4300+

100%
Yes 100¢No 0¢
—
N/A
$2,971
N/A
N/A
N/A
Settled
Yes
polymarket

4200+

100%
Yes 100¢No 0¢
—
N/A
$1,453
N/A
N/A
N/A
Settled
Yes
polymarket

4000+

100%
1%
Yes 100¢No 0¢
—
N/A
$1,287
N/A
N/A
N/A
Settled
Yes
polymarket

3900+

100%
2%
Yes 100¢No 0¢
—
N/A
$1,218
N/A
N/A
N/A
Settled
Yes
polymarket

3700+

100%
Yes 100¢No 0¢
—
N/A
$376
N/A
N/A
N/A
Settled
Yes
polymarket

4100+

100%
Yes 100¢No 0¢
—
N/A
$211
N/A
N/A
N/A
Settled
Yes
polymarket

3800+

100%
Yes 100¢No 0¢
—
N/A
$105
N/A
N/A
N/A
Settled
Yes
polymarket

4900+

0%
Yes 0¢No 100¢
—
N/A
$9,531
N/A
N/A
N/A
Settled
No
Total markets: 11

Description

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Polymarket

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Frequently asked questions

Currently, this market reflects a collective prediction about the U.S. measles case count that may differ from traditional analyst forecasts or public health polls. While external sources might offer projections on measles incidence, this market represents a real-money view, where participants put their capital behind their beliefs. It’s possible that this market’s implied probability distribution aligns with expert opinions, or it could reveal a different assessment based on factors not fully captured in conventional analyses. Comparing the outcome of this market to those forecasts after Nov 1, 2026 will be insightful.

This market resolves around Nov 1, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. The final U.S. measles case count will be sourced from official public health organizations, such as the Centers for Disease Control and Prevention (CDC), and will determine whether the market settles in favor of a particular outcome range. The resolution will be based on the total number of confirmed measles cases reported in the United States by October 31, 2026, as documented by these official sources.

Several factors could significantly influence this market before Nov 1, 2026. Major outbreaks of measles in densely populated areas, changes in vaccination rates, or the emergence of new measles strains could all shift trader sentiment. Public health announcements from the CDC regarding vaccination campaigns or outbreak control measures would also be key catalysts. Additionally, any significant news coverage related to measles cases or vaccination efforts could impact trading activity and the price of shares in this market. Monitoring these events will be crucial for understanding market movements.